NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
This Quarter Return
-14.02%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$123M
AUM Growth
+$123M
Cap. Flow
-$7.25M
Cap. Flow %
-5.87%
Top 10 Hldgs %
81.99%
Holding
44
New
1
Increased
4
Reduced
3
Closed
5

Top Buys

1
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$2.09M
2
GERN icon
Geron
GERN
$775K
3
ATHA icon
Athira Pharma
ATHA
$340K
4
KALV icon
KalVista Pharmaceuticals
KALV
$287K
5
CABA icon
Cabaletta Bio
CABA
$91.7K

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$4.41M
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$4.38M
3
OCS icon
Oculis Holding
OCS
$489K
4
GTLB icon
GitLab
GTLB
$353K
5
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$336K

Sector Composition

1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$38.2M 30.9% 225,688 – –
ILMN icon
2
Illumina
ILMN
$15.8B
$16.4M 13.25% 119,196 – –
HRMY icon
3
Harmony Biosciences
HRMY
$2.12B
$12.1M 9.78% 368,665 – –
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
$9.99M 8.09% 47,096 – –
OCS icon
5
Oculis Holding
OCS
$844M
$6.67M 5.4% 606,684 -44,416 -7% -$489K
SLGC
6
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$4.05M 3.28% 1,696,558 – –
EXAI
7
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$3.89M 3.15% 859,892 – –
XENE icon
8
Xenon Pharmaceuticals
XENE
$2.98B
$3.64M 2.95% 106,680 -7,700 -7% -$263K
MRUS icon
9
Merus
MRUS
$4.98B
$3.23M 2.62% 137,038 -13,962 -9% -$329K
REPL icon
10
Replimune Group
REPL
$422M
$3.16M 2.56% 184,739 – –
KALV icon
11
KalVista Pharmaceuticals
KALV
$678M
$2.26M 1.83% 234,573 +29,853 +15% +$287K
ONC
12
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$2.16M 1.75% 12,022 – –
ALPN
13
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$2.09M 1.69% +182,280 New +$2.09M
INCY icon
14
Incyte
INCY
$16.5B
$1.85M 1.5% 32,022 – –
GERN icon
15
Geron
GERN
$893M
$1.6M 1.29% 753,550 +365,550 +94% +$775K
EXEL icon
16
Exelixis
EXEL
$10.1B
$1.4M 1.14% 64,200 – –
BOLT icon
17
Bolt Biotherapeutics
BOLT
$9.85M
$1.21M 0.98% 1,166,952 – –
PACB icon
18
Pacific Biosciences
PACB
$393M
$1.14M 0.92% 136,655 – –
RANI icon
19
Rani Therapeutics
RANI
$24.4M
$1.07M 0.87% 493,584 – –
RYTM icon
20
Rhythm Pharmaceuticals
RYTM
$6.85B
$919K 0.74% 40,070 – –
TRDA icon
21
Entrada Therapeutics
TRDA
$208M
$775K 0.63% 49,082 – –
CABA icon
22
Cabaletta Bio
CABA
$133M
$718K 0.58% 47,150 +6,027 +15% +$91.7K
ARGX icon
23
argenx
ARGX
$43.6B
$703K 0.57% 1,430 – –
JBIO
24
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$650K 0.53% 47,936 – –
ACAD icon
25
Acadia Pharmaceuticals
ACAD
$4.38B
$625K 0.51% 29,984 – –
1
2